These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1001871)

  • 21. [The mechanism of potentiation of the antitumor effect of 5-fluorouracil by methionine-free intravenous amino acid solution (AO-90) in rats].
    Hibino Y; Kawarabayashi Y; Kohri H; Ueda N; Tsukagoshi S
    Gan To Kagaku Ryoho; 1994 Sep; 21(12):2021-8. PubMed ID: 8085853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of cell-cycle information in the preparation of drug combinations: results with cytosine arabinoside plus actinomycin D1,2.
    Bhuyan BK; Fraser TJ; Day KJ
    Cancer Treat Rep; 1976 Dec; 60(12):1813-8. PubMed ID: 1036090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A model for the chemotherapy of acute leukemia with 1-beta-D-arabinofuranosylcytosine.
    Momparler RL
    Cancer Res; 1974 Aug; 34(8):1775-87. PubMed ID: 4526298
    [No Abstract]   [Full Text] [Related]  

  • 24. Therapy of central nervous system leukemia in mice by liposome-entrapped 1-beta-D-arabinofuranosylcytosine.
    Hong F; Mayhew E
    Cancer Res; 1989 Sep; 49(18):5097-102. PubMed ID: 2766280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Timunox increases resistance to the challenge with a low number of cells from Yoshida ascites tumor.
    Licastro G; Bottari C; Cavallaro A; Ainis T; Fimiani V
    J Chemother; 1989 Jul; 1(4 Suppl):1172-3. PubMed ID: 16312820
    [No Abstract]   [Full Text] [Related]  

  • 26. [Invention of a tumor-selective 5-fluorouracil derivative named S-1 by biochemical modulation of 5-fluorouracil].
    Shirasaka T; Shimamoto Y; Kato T; Fukushima M
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):371-84. PubMed ID: 9492831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective targeting of magnetic albumin microspheres containing low-dose doxorubicin: total remission in Yoshida sarcoma-bearing rats.
    Widder KJ; Morris RM; Poore GA; Howard DP; Senyei AE
    Eur J Cancer Clin Oncol; 1983 Jan; 19(1):135-9. PubMed ID: 6682771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preliminary study of the optimal dosing schedule for oral UFT/leucovorin chemotherapy.
    Sadahiro S; Suzuki T; Ishikawa K; Nakamura T; Saguchi T; Kamijo A; Yasuda S; Makuuchi H; Murayama C
    Anticancer Res; 2004; 24(2B):625-30. PubMed ID: 15161004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Schedule-dependent synergism of combinations of hydroxyurea with adriamycin and 1-beta-D-arabinofuranosylcytosine with adriamycin.
    Ritch PS; Occhipinti SJ; Cunningham RE; Shackney SE
    Cancer Res; 1981 Oct; 41(10):3881-4. PubMed ID: 7284997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Affinity of intraperitoneally injected activated carbon particles adsorbing mitomycin C to tumor surface of Yoshida sarcoma.
    Hagiwara A; Takahashi T; Iwamoto A; Yoneyama C; Itoh M; Sasabe T
    Anticancer Drug Des; 1990 Nov; 5(4):359-69. PubMed ID: 2127181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on two variant strains of Yoshida sarcoma characterized by island formation in ascites.
    Ishidate M; Isaka H
    Gan; 1966 Aug; 57(4):413-26. PubMed ID: 5338890
    [No Abstract]   [Full Text] [Related]  

  • 32. [Experimental studies on the antitumor effect of progesterone and enhancement of the therapeutic effect of anticancer drugs by progesterone--from the aspect of zinc metabolism].
    Ujiie S; Mimata Y; Okuno M; Wakui A
    Gan To Kagaku Ryoho; 1989 Jul; 16(7):2423-8. PubMed ID: 2751319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inosine pranobex-BAN increases the resistance to the challenge with cells or cell-free fluid from Yoshida ascites tumor.
    Fimiani V; Cavallaro A; Falliti G; Amato A
    Chemioterapia; 1986 Apr; 5(2):128-33. PubMed ID: 2423256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of incipient growth of Yoshida sarcoma in vivo after transplantation of a small number of tumor cells.
    Ashihara T
    Gan; 1976 Feb; 67(1):75-80. PubMed ID: 1269858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Some effects of chlorambucil on the chromatin of Yoshida ascites sarcoma cells.
    Riches PG; Harrap KR
    Cancer Res; 1973 Feb; 33(2):389-93. PubMed ID: 4688885
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of tetrahydrouridine on the action of 1-beta-D-arabinofuranosylcytosine in synchronized cultures of normal rat kidney cells.
    Wan CW; Mak TW
    Cancer Res; 1979 Oct; 39(10):3981-5. PubMed ID: 476637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Production of N4-succinyl-1-beta-D-arabinofuranosylcytosine, a novel metabolite of N4-behenoyl-1-beta-D-arabinofuranosylcytosine, in mice and its biological significance.
    Oh-ishi J; Kataoka T; Tsukagoshi S; Sakurai Y; Shibukawa M; Kobayashi H
    Cancer Res; 1981 Jun; 41(6):2501-6. PubMed ID: 7237444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histidinol-mediated improvement in the specificity of 1-beta-D-arabinofuranosylcytosine and 5-fluorouracil in L 1210 leukemia-bearing mice.
    Warrington RC; Muzyka TG; Fang WD
    Cancer Res; 1984 Jul; 44(7):2929-35. PubMed ID: 6722819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of prolonged administration of -aminocaproic acid and sintrom on metastases of Yoshida sarcoma to the lungs in rats.
    Lawiński M; Szacki J; Grzebieluch M; Kotschy M
    Arch Immunol Ther Exp (Warsz); 1971; 19(4):523-32. PubMed ID: 5095071
    [No Abstract]   [Full Text] [Related]  

  • 40. Synergistic effects of bis(3-methylsulfonyloxypropyl)-amine toluenesulfonate (864-T) with 6-mercaptopurine and other antitumor agents.
    Imamura H; Ikegami K; Okumoto T
    Gan; 1973 Oct; 64(5):427-31. PubMed ID: 4358730
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.